[{"abstract": "Amid a weak merger market, drug makers are striking a flurry of deals, with Pfizer agreeing to sell its infant nutrition unit to Nestl\u00e9 for $11.9 billion on Monday.", "web_url": "https://dealbook.nytimes.com/2012/04/23/a-hot-time-for-health-care-deals/", "snippet": "Amid a weak merger market, drug makers are striking a flurry of deals, with Pfizer agreeing to sell its infant nutrition unit to Nestl\u00e9 for $11.9 billion on Monday.", "lead_paragraph": "If mergers activity rises this year, as ever-optimistic deal makers say will happen, health care transactions will help lead the way.", "source": "The New York Times", "multimedia": [], "headline": {"main": "A Hot Time for Health Care Deals", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "AMYLIN PHARMACEUTICALS INC", "rank": 1, "major": "N"}, {"name": "organizations", "value": "AstraZeneca PLC", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Bristol Myers Squibb Company", "rank": 3, "major": "N"}, {"name": "organizations", "value": "GlaxoSmithKline PLC", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Human Genome Sciences Inc", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Illumina Inc", "rank": 6, "major": "N"}, {"name": "organizations", "value": "Nestle SA", "rank": 7, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 8, "major": "N"}, {"name": "organizations", "value": "Roche Holding AG", "rank": 9, "major": "N"}], "pub_date": "2012-04-23T13:16:12+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Michael J. de la Merced", "person": [{"firstname": "Michael", "middlename": "J.", "lastname": "de la Merced", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/6dd373dc-93c7-540a-86a7-ae4c708372d5", "word_count": 514, "uri": "nyt://article/6dd373dc-93c7-540a-86a7-ae4c708372d5"}, {"abstract": "Adding to a flurry of health care deals announced on Monday, Thomson Reuters has sold its health care unit to an affiliate of Veritas Capital for $1.25 billion in cash.", "web_url": "https://dealbook.nytimes.com/2012/04/23/thomson-reuters-sells-healthcare-business-for-1-25-billion/", "snippet": "Adding to a flurry of health care deals announced on Monday, Thomson Reuters has sold its health care unit to an affiliate of Veritas Capital for $1.25 billion in cash.", "lead_paragraph": "On a rather active Merger Monday highlighted by two health care acquisitions \u2013 Nestl\u00e9\u2019s $11.9 billion purchase of the infant nutrition unit of Pfizer and AstraZeneca\u2019s $1.26 billion buyout of Ardea Biosciences \u2013 Thomson Reuters is adding one more deal to the mix.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Thomson Reuters Sells Health Care Business for $1.25 Billion", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2012-04-23T14:31:54+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Kevin Roose", "person": [{"firstname": "Kevin", "middlename": null, "lastname": "Roose", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/93e7f9ed-834c-53f0-96ac-77af2d2c0661", "word_count": 247, "uri": "nyt://article/93e7f9ed-834c-53f0-96ac-77af2d2c0661"}, {"abstract": "By agreeing to acquire Pfizer\u2019s infant nutrition business for $11.9 billion, the Swiss food giant Nestl\u00e9 is paying a high premium to gain access to the baby food markets in emerging countries.", "web_url": "https://dealbook.nytimes.com/2012/04/23/nestle-pays-a-high-price-for-pfizer-unit/", "snippet": "By agreeing to acquire Pfizer\u2019s infant nutrition business for $11.9 billion, the Swiss food giant Nestl\u00e9 is paying a high premium to gain access to the baby food markets in emerging countries.", "lead_paragraph": "Nestl\u00e9 is throwing down its cash.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Nestle Pays a High Price for Pfizer Unit", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Baby Foods", "rank": 1, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Nestle SA", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 4, "major": "N"}], "pub_date": "2012-04-23T17:30:49+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Mark Scott", "person": [{"firstname": "Mark", "middlename": null, "lastname": "Scott", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/8fc1fc73-7c99-5db1-8f6b-bef8c5fd7ca6", "word_count": 332, "uri": "nyt://article/8fc1fc73-7c99-5db1-8f6b-bef8c5fd7ca6"}]